Label: information for the patient
Auxina E 50 UI soft capsules
Vitamin E (dl-alfa tocopheryl acetate)
Read this label carefully before starting to take this medication, as it contains important information for you.
Contains vitamin E (liposoluble). The most well-known function of vitamin E is its ability to act as a fatty substance antioxidant. It prevents the oxidation of essential cellular elements and/or avoids the formation of toxic oxidation products.
Auxina E 50 is indicated for:
Do not take Auxina E 50
Warnings and precautions
Consult your doctor or pharmacist before starting to take Auxina E 50.
Children and adolescents
This medication may be administered to children. However, the pharmaceutical form may not be suitable for young children, as they may have difficulty swallowing it.
Taking Auxina E 50 with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.
The following medications may interact with Auxina E 50 when used at the same time:
- Oral anticoagulants (medications to make the blood more fluid), such as acenocoumarol, warfarin, dicumarol, as vitamin E increases their effect.
- Tocopherol succinate (a form of vitamin E), which may increase the effect of this medication.
- Estrogens, including oral contraceptives.
Medications affecting the gastrointestinal absorption of vitamin E:
- Cholestyramine and cholestipol (to reduce cholesterol levels)
- Orlistat (to reduce fat absorption)
- Mineral oil or liquid paraffin (helping to evacuate the intestine)
If taken together, doses should be spaced at least 2 hours apart.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor before using this medication.
As a precaution, do not take Auxina E 50 during pregnancy.
There is no information on the excretion of vitamin E in breast milk, so this medication may have some effect on the newborn/child.
This medication should not be used during breastfeeding.
Driving and operating machines
Auxina E 50 has no influence on the ability to drive and operate machines.
Auxina E 50 contains sodium methylparahydroxybenzoate (E-219), sodium propylparahydroxybenzoate (E-217) and Red Ponceau 4R (E-124)
It may cause allergic reactions (possibly delayed) because it contains sodium methylparahydroxybenzoate and sodium propylparahydroxybenzoate.
This medication may cause allergic reactions because it contains Red Ponceau 4R.
It may cause asthma, especially in patients allergic to acetylsalicylic acid.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Auxina E 50 is taken orally. The recommended dose is:
Adults and children over 10 years old:
The capsules must be swallowed whole with a little water or other liquid, during or after meals.
Use in children
Auxina E 50 soft capsules can be administered to children. However, the pharmaceutical form of this medication may not be suitable for young children, as they may have difficulty swallowing them.
If you take more Auxina E 50 than you should
Vitamin E in excessive doses (generally doses above 300 mg) can cause nausea, diarrhea, and other digestive disorders, and in predisposed individuals, it can cause thrombophlebitis and worsen coagulation problems; it can also cause gonadal dysfunction, breast pain, increased cholesterol and triglycerides, and reduced thyroid hormones in the blood.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or go to a medical center or call the Toxicology Information Service, Tel.: 91 5620420, indicating the medication and the amount ingested.
If you forgot to take Auxina E 50
Do not take a double dose to compensate for the missed doses.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may produce adverse effects, although not all people will experience them.
Among these adverse effects, whose frequency is not exactly known, are:
Digestive disorders (in general, prolonged treatment and high doses), such asdiarrhea, nausea, stomach discomfort, intestinal cramps, gum bleeding.
Circulation disorders, more likely in predisposed patients, such asthrombophlebitis (swelling of a vein caused by a blood clot) and bleeding tendency (in general, prolonged treatment and high doses).
In general, prolonged treatment and high doses, fatigue, weakness, dizziness, headache; there have been some cases of cerebral infarction.
Rarely, emotional disturbances, fatigue.
Blurred vision, in general, prolonged treatment and high doses.
Mastalgia, alteration in the functioning of the gonads (sex glands).
Alterations in clinical analysis results, such as creatine determination, creatine kinase, sex hormones, and thyroid hormones.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is about possible adverse effects that do not appear in this prospectus. You can also report them directly through the national notification system, Spanish System of Pharmacovigilance of Medicinal Products for Human Use: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information about the safety of this medication.
Do not store at a temperature above25ºC.
Store in the original packaging to protect it from humidity.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Auxina E 50
Appearance of the product and contents of the packaging
Auxina E 50 are soft, round, transparent red gelatin capsules with a yellowish oily solution.
It is presented in packaging of 20 and 60 capsules.
Auxina E 200 UI
Auxina E 400 UI
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
CHIESI ESPAÑA, S.A.U.
Plaça d´Europa, 41-43, 10th floor
08908, L´Hospitalet de Llobregat
Barcelona (Spain)
Tel 934948000
Responsible for manufacturing
Laboratorios Alcalá Farma S.L.
Avenida de Madrid, 82
28802 - Alcalá de Henares
Madrid
Last review date of this leaflet: March 2014.
Other sources of information
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http:/www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.